Anaveon Unveils Refreshed Brand Identity and Website

Anaveon, a biopharmaceutical company that specializes in the development of treatments for diseases with immune system dysfunction, today reveals a refreshed brand and website.

The website is a reflection of who we are, our approach and science, and what our goal is; to harness the power of engineered cytokines and develop novel treatments for diseases with high unmet need.

We invite you to explore the new www.anaveon.com and discover more about our vision and scientific approach to cutting-edge immunology.

ENDS

Media contact :
JW Communications
Julia Wilson
Email: julia.wilson@anaveon.com

About Anaveon:

Anaveon is a biopharmaceutical company that specializes in the development of treatments for diseases with immune system dysfunction. Founded in 2017 by leading experts in the field of immunotherapy, Anaveon’s goal is to harness the power of engineered cytokines and develop novel treatments for diseases with high unmet need.

The first program going into clinical trials is a selective interleukin-2 (IL-2) receptor agonist, a type of protein that can enhance a patient’s immune system in order to target and defeat tumors. Find out more at anaveon.com.

 

4
Share Share It FB TW GP